Connect Biopharma Holdings Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | -81.8% | +92.9% | +1,746.6% | -75.2% | -2.5% | -33.2% | +6.7% | |
| – | – | +5.1% | +9,696.6% | -98.3% | +223.1% | +106.4% | -44.6% | |
| – | +357.2% | +903.1% | +20.1% | – | – | – | – | |
| – | – | -118.3% | – | -65.6% | +32.5% | -263.3% | – | |
| – | -86.9% | +1,407.4% | +1,927.3% | -91.0% | -93.1% | +155.1% | -42.1% | |
| – | -100.8% | – | -7,675.4% | +145.2% | – | -104.6% | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | – | – | |
| – | +33.2% | +20.9% | +49.6% | -72.4% | +30.6% | – | – | |
| – | -100.0% | – | +835.1% | -100.0% | +169.5% | – | +381.5% | |
| – | -103.7% | – | +548.8% | -124.2% | – | -201.6% | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.